In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  voriconazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: Other
Protocol IDs: 2005-004973-55, ANTIVORIFUNGOL, NCT00386802

2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501038, NCT00143312

3.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: Other
Protocol IDs: EORTC-19961, PFIZER-150-307-000, NCT00003031

4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-98-C-0063, PFIZER-150-603

5.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501029, NCT00150345

7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 2 to 12
Sponsor: NCI, NHLBI
Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A8851009, NCT00531479

9.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0443, NCT00904995

10.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9766-CL-0104, WSA-CS-004, 2006-003868-59, NCT00412893

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 and over
Sponsor: NCI
Protocol IDs: CDR0000298887, NCI-03-C-0111, NCT00059878

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 to 11
Sponsor: NCI
Protocol IDs: CDR0000316329, NCI-03-C-0218, NCT00066599

13.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0536, NCT00418951

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: A1501096, NCT01383993

15.

Phase: Phase I
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MCV-CCHR-9603-2H, PFIZER-95CK39-0673, NCI-G97-1325

16.

Phase: Phase I
Type: Supportive care
Status: Completed
Age: 2 to 12
Sponsor: NCI
Protocol IDs: NCI-00-C-0150

17.

Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000355116, P30CA016042, UCLA-0307071, NCT00079222

18.

Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NHLBI
Protocol IDs: 139, NCT00023530

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PMH-VOR, NCT01321372

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 8 and over
Sponsor: NCI
Protocol IDs: 060198, 06-C-0198, NCT00353158
New Search